glp-1 drugs canada greenlights first daily pill for heart and diabetes π¨π¦ Canada just became the
Description
Glucagon-like peptide-1 (GLP-1) agonists are a class of medications originally developed to manage type 2 diabetes mellitus and, more recently, obesity
However, a recent large meta-analysis showed no association between these three variants and low bone mineral density or fracture prevalence (102)
Dong, M., Koole, C., Wootten, D., Sexton, P
The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease
[DOI] [PMC free article] [PubMed] [Google Scholar] 292.Keenan S.J., Cooke M.B., Hassan E.B., Chen W.S., Sullivan J., Wu S.X., El-Ansary D., Imani M., Belski R
